Pfizer Inc. (PFE)

35.76
0.05 0.14
NYSE : Health Technology
Prev Close 35.71
Open 35.61
Day Low/High 35.43 / 35.75
52 Wk Low/High 31.67 / 39.43
Volume 14.93M
Avg Volume 21.70M
Exchange NYSE
Shares Outstanding 5.85B
Market Cap 208.77B
EPS 3.60
P/E Ratio 9.92
Div & Yield 1.36 (3.64%)

Latest News

3 Cutting-Edge Biotech Stocks That Can Double in Value

3 Cutting-Edge Biotech Stocks That Can Double in Value

These three "strong buy" biotech stocks are primed for outsized growth in the next 12 months. Here's why.

Being Bullish on Trump Surprisingly Worked Well for Investors This Week

Being Bullish on Trump Surprisingly Worked Well for Investors This Week

President Trump reduced tensions in Korea, raised them in the Middle East, and mainly relieved them for investors in the drug and healthcare industries.

Healthcare Stocks Rebound After President Trump's Speech on Drug Pricing

Healthcare Stocks Rebound After President Trump's Speech on Drug Pricing

President Trump delivered a highly-anticipated speech on lowering the cost of drugs for Americans on Friday afternoon.

Mylan First-Quarter Revenue Misses Estimate Amid Lower Sales of Branded Product

Mylan First-Quarter Revenue Misses Estimate Amid Lower Sales of Branded Product

The EpiPen maker saw a 19% drop in North America net sales due in part to lower sales of branded products.

Pfizer Becomes #3 Most Shorted Dow Stock, Replacing Intel

The most recent short interest data has been released for the 04/13/2018 settlement date, and we here at Dividend Channel like to sift through this fresh data and order the underlying components of the Dow Jones Industrial Average by "days to cover." There are a number of ways to look at short data, for example the total number of shares short; but one metric that we find particularly useful is the "days to cover" metric because it considers both the total shares short and the average daily volume of shares typically traded. The number of shares short is then compared to the average daily volume, in order to calculate the total number of trading days it would take to close out all of the open short positions if every share traded represented a short position being closed.

Broker Darlings Of The Dow: Pfizer Ranks As A Top 15 Analyst Pick

A study of analyst recommendations at the major brokerages shows that Pfizer Inc is the #15 broker pick, on average, out of the 30 stocks making up the Dow Jones Industrial Average, according to ETF Channel. Within the broader S&P 500, when components were ranked in terms of analyst favorites, PFE claims the #235 spot.

Surveying the M&A Landscape in Biotech

Surveying the M&A Landscape in Biotech

Who might be in play in the quarters ahead?

Dow Declines as S&P 500 and Nasdaq Finish Higher

Dow Declines as S&P 500 and Nasdaq Finish Higher

Stocks were mixed on Tuesday with investors adopting a cautious stance as the Federal Reserve begins a two-day meeting.

Apple, BP, Boeing, Pfizer and Merck - 5 Things You Must Know

Apple, BP, Boeing, Pfizer and Merck - 5 Things You Must Know

U.S. stock futures are mixed as the Federal Reserve kicks off a two-day meeting and Apple is scheduled to report quarterly results.

Wall Street Futures Edge Lower, Oil Holds Gains; Markets Await Apple Earnings

Wall Street Futures Edge Lower, Oil Holds Gains; Markets Await Apple Earnings

Global stocks bumped higher Tuesday, while oil prices held at three-and-a-half year highs, amid several key market closures and ahead of what could be a crucial quarterly earnings update from Apple after the close of trading.

Are Apple's Best Days in the Past?: Market Recon

Are Apple's Best Days in the Past?: Market Recon

I think it very possible that there will be a positive reaction tonight, more likely based on what Tim Cook says.

PFIZER REPORTS FIRST-QUARTER 2018 RESULTS

null

What to Expect From Allergan, Aetna, Merck and Pfizer's Earnings Next Week

What to Expect From Allergan, Aetna, Merck and Pfizer's Earnings Next Week

The drugmakers and health insurer are preparing to unveil first-quarter numbers.

Pfizer Hosts Annual Meeting Of Shareholders

null

Fate of Pfizer Unit in Spotlight After Merck Sells Consumer Business

Fate of Pfizer Unit in Spotlight After Merck Sells Consumer Business

Procter & Gamble, which is buying the Merck unit, was previously reported to be in talks to acquire Pfizer's consumer healthcare business.

Alkermes Wins Quick Reversal From FDA on Antidepressant Drug

Alkermes Wins Quick Reversal From FDA on Antidepressant Drug

Two weeks ago, the agency told Alkermes it needed more trials for antidepressant drug candidate ALKS-5461. The agency, however, had a change of heart, sending shares jumping on the news.

U.S. Senator Cory Booker Criticizes Pharma Companies in New Tax Report

U.S. Senator Cory Booker Criticizes Pharma Companies in New Tax Report

The Trump Administration cut corporate taxes and U.S. Senator Cory Booker hoped pharma companies would cut drug prices. That didn't happen and Booker's new analysis hammers those drug companies.

Trump's China Tariffs Could Hurt Generic Drug Companies and Increase Prices

Trump's China Tariffs Could Hurt Generic Drug Companies and Increase Prices

As President Trump tees up a set of 25% tariffs on a wide range of products against China trade, generic drug makers as well as their patients likely will be affected.

TheStreet Quant Rating: B (Buy)